JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1999; 33:932-938
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cowburn, P. J.
Right arrow Articles by Morton, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cowburn, P. J.
Right arrow Articles by Morton, J. J.

CLINICAL STUDIES

EndothelinB receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction

Peter J. Cowburn, MBBS, MRCP* {dagger}, John G. F. Cleland, MD, FRCP, FESC, FACC{ddagger}, John D. McArthur, MB, ChB, FRCP{dagger}, Margaret R. MacLean, PhD* {dagger}, John J. V. McMurray, BSc, MD, FRCP, FESC* {dagger}, Henry J. Dargie, MB, ChB, FRCP, FESC* {dagger} and James J. Morton, PhD* {dagger}

* Medical Research Council Clinical Research Initiative in Heart Failure, University of Glasgow, Glasgow, Scotland, United Kingdom
{dagger} Department of Cardiology, Western Infirmary, Glasgow, Scotland, United Kingdom
{ddagger} The Academic Unit, Department of Cardiology, Kingston-upon-Hull, United Kingdom

Manuscript received February 12, 1998; revised manuscript received August 25, 1998, accepted December 4, 1998.

Reprint requests and correspondence: Dr. John G. F. Cleland, Castle Hill Hospital, Castle Road, Cottingham Hull, HU16 5JQ, United Kingdom
J.Cleland{at}bio.gla.ac.uk

OBJECTIVES

This study was designed to assess the functional importance of endothelin (ET)B receptors in patients with left ventricular systolic dysfunction (LVSD) by comparing the hemodynamic effects of ET-1, a nonselective ETA and ETB agonist, with ET-3, a selective ETB receptor agonist.

BACKGROUND

Knowledge of the functional importance of ETB receptors in mediating vasoconstriction in chronic heart failure will help determine whether antagonists at both ETA and ETB receptors are required to fully prevent vasoconstriction to endogenously produced ET-1.

METHODS

We infused ET-1 (5 and 15 pmol/min) and ET-3 (5 and 15 pmol/min) into two separate groups of eight patients with LVSD with similar baseline hemodynamic indices. Hemodynamics were measured using a pulmonary thermodilution catheter and an arterial line.

RESULTS

Endothelin-1 infusion led to systemic vasoconstriction, with a rise in mean arterial pressure (mean ± SEM 100 ± 3 to 105 ± 3 mm Hg, p < 0.02) and systemic vascular resistance (1,727 ± 142 to 2,055 ± 164 dyn/s/cm–5, p < 0.001) and a fall in cardiac index (2.44 ± 0.21 to 2.22 ± 0.20 liters/min/m2, p < 0.01). Endothelin-3 infusion also led to systemic vasoconstriction, with a rise in mean arterial pressure (99 ± 6 to 105 ± 6 mm Hg, p < 0.01) and systemic vascular resistance (1,639 ± 210 to 1,918 ± 245 dyn/s/cm–5, p < 0.01) and a fall in cardiac index (2.66 ± 0.28 to 2.42 ± 0.24 liters/min/m2, p < 0.05). Pulmonary hemodynamic measurements did not change significantly in either group.

CONCLUSIONS

Both ET-1 and ET-3 infusions led to systemic vasoconstriction; the hemodynamic changes observed were of a similar magnitude at the same molar concentration. This suggests that ETB receptors are functionally important in mediating vasoconstriction, at least in the systemic circulation, in patients with LVSD.

Abbreviations and Acronyms
  CHF = chronic heart failure
  CI = cardiac index
  CO = cardiac output
  DCM = dilated cardiomyopathy
  ET = endothelin
  LVSD = left ventricular systolic dysfunction
  MPAP = mean pulmonary artery pressure
  PCWP = pulmonary capillary wedge pressure
  PVR = pulmonary vascular resistance
  RAP = right atrial pressure
  SNP = sodium nitroprusside
  SVR = systemic vascular resistance




This article has been cited by other articles:


Home page
HypertensionHome page
J. P.J. Halcox, K. R.A. Nour, G. Zalos, and A. A. Quyyumi
Endogenous Endothelin in Human Coronary Vascular Function: Differential Contribution of Endothelin Receptor Types A and B
Hypertension, May 1, 2007; 49(5): 1134 - 1141.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. S. Gottlieb
The neurohormonal paradigm:have we gone too far?
J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1458 - 1459.
[Full Text] [PDF]


Home page
Circ. Res.Home page
T. Dschietzig, C. Bartsch, C. Richter, M. Laule, G. Baumann, and K. Stangl
Relaxin, a Pregnancy Hormone, Is a Functional Endothelin-1 Antagonist: Attenuation of Endothelin-1-Mediated Vasoconstriction by Stimulation of Endothelin Type-B Receptor Expression via ERK-1/2 and Nuclear Factor-{kappa}B
Circ. Res., January 10, 2003; 92(1): 32 - 40.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Ooi, W. S. Colucci, and M. M. Givertz
Endothelin Mediates Increased Pulmonary Vascular Tone in Patients With Heart Failure: Demonstration by Direct Intrapulmonary Infusion of Sitaxsentan
Circulation, September 24, 2002; 106(13): 1618 - 1621.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P.J. Cowburn and J.G.F. Cleland
Endothelin antagonists for chronic heart failure: do they have a role?
Eur. Heart J., October 1, 2001; 22(19): 1772 - 1784.
[PDF]


Home page
CirculationHome page
K. Asai, R. K. Kudej, G. Takagi, A. B. Kudej, F. Natividad, Y.-T. Shen, D. E. Vatner, and S. F. Vatner
Paradoxically Enhanced Endothelin-B Receptor-Mediated Vasoconstriction in Conscious Old Monkeys
Circulation, May 15, 2001; 103(19): 2382 - 2386.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. E. Spieker, G. Noll, F. T. Ruschitzka, and T. F. Luscher
Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1493 - 1505.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. F. Luscher and M. Barton
Endothelins and Endothelin Receptor Antagonists : Therapeutic Considerations for a Novel Class of Cardiovascular Drugs
Circulation, November 7, 2000; 102(19): 2434 - 2440.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. P Love, C. J Ferro, W. G Haynes, C. Plumpton, A. P Davenport, D. J Webb, and J. J.V McMurray
Endothelin receptor antagonism in patients with chronic heart failure
Cardiovasc Res, July 1, 2000; 47(1): 166 - 172.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. M. Givertz, W. S. Colucci, T. H. LeJemtel, S. S. Gottlieb, J. M. Hare, M. T. Slawsky, C. V. Leier, E. Loh, J. M. Nicklas, and B. E. Lewis
Acute Endothelin A Receptor Blockade Causes Selective Pulmonary Vasodilation in Patients With Chronic Heart Failure
Circulation, June 27, 2000; 101(25): 2922 - 2927.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. E. Spieker, V. Mitrovic, G. Noll, R. Pacher, M. R. Schulze, J.o. Muntwyler, C. Schalcher, W. Kiowski, T. F. Luscher, and on behalf of the ET 003 Investigators
Acute hemodynamic and neurohumoral effects of selective ETA receptor blockade in patients with congestive heart failure
J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1745 - 1752.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1999 by the American College of Cardiology Foundation.